To protect you from COVID-19, we are offering a quick & easy remote intake process. Click here to learn more.
Many antidepressants are classified as selective serotonin reuptake inhibitors or SSRI. There are multiple SSRI on the market including:
According to some studies, SSRIs are linked to serious birth defects including persistent pulmonary hypertension of the newborn or PPHN.
Facts about SSRI Birth Defects:
· The New England Journal of Medicine study found that women who took SSRIs during their third trimester were six times more likely to deliver babies born with PPHN-or to have babies that would develop primary pulmonary hypertension-than women who did not take SSRIs during their third trimmest.
· A 2005 Danish study determined that infants that were exposed to SSRIs during the first trimester of pregnancy were found to have a 60% higher chance of developing congenital heart defects.
· Paxil and Effexor were both highlighted by the FDA in 2005 for warnings associated with these risks.
· Two years before the FDA approval of Prozac in 1998, a 1996 study published in the New England Journal of Medicine revealed that women taking Prozac during pregnancy were twice as likely to deliver a baby with three or more “minor abnormalities” and below average neonatal adaptation.
· In 2004, Health Canada advised of the potential serious adverse effects of SSRI antidepressants of newborns.
If you or a loved one has taken an SSRI drug and has a child that suffers from a birth defect or from PPHN, the lawyers at the Manchin Injury Law Group can help. Contact us today for more information.